Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Atagi, Shinji
49  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Clinical benefit of platinum doublet combination therapy in..:

Shimokawa, Mototsugu ; Kanazu, Masaki ; Saito, Ryusei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260489/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Standard versus low‐dose nab‐paclitaxel in previously treat..:

Takeuchi, Susumu ; Kubota, Kaoru ; Sugawara, Shunichi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166935/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

A randomized phase III study of docetaxel alone versus doce..:

Atagi, Shinji ; Daimon, Takashi ; Okishio, Kyoichi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569902/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Transient IGF-1R inhibition combined with osimertinib eradi..:

Wang, Rong ; Yamada, Tadaaki ; Kita, Kenji...
http://repo.lib.tokushima-u.ac.jp/files/public/11/116609/2021121715282023254/ncomms_11_4607.pdf.  , 2022
Link: http://repo.lib.tokushim..
 
?
5

A multicenter, open‐label, single‐arm study of anamorelin (..:

Naito, Tateaki ; Uchino, Junji ; Kojima, Toru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303784/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Health-Related Quality of Life Outcomes in Patients with Re..:

Majem, Margarita ; Goldman, Jonathan W ; John, Thomas...
Clinical Cancer Research.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
7

Health-Related Quality of Life Outcomes in Patients with Re..:

Majem, Margarita ; Goldman, Jonathan W ; John, Thomas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359973/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Retrospective analysis of long‐term survival factors in pat..:

Murakami, Yusuke ; Tamiya, Akihiro ; Taniguchi, Yoshihiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841702/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

A randomized phase II study of docetaxel or pemetrexed with..:

Asami, Kazuhiro ; Ando, Masahiko ; Nishimura, Takashi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200881/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

A quantitative evaluation of the histological type dependen..:

Kojima, Kensuke ; Sakamoto, Tetsuki ; Kasai, Takahiko..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894954/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Durvalumab as third-line or later treatment for advanced no..:

Garassino, Marina, Chiara ; Cho, Byoung-Chul ; Kim, Joo-Hang...
info:eu-repo/semantics/altIdentifier/doi/10.1016/s1470-2045(18)30144-x.  , 2020
Link: https://hal.u-pec.fr/hal..
 
?
12

Durvalumab as third-line or later treatment for advanced no..:

Garassino, Marina, Chiara ; Cho, Byoung-Chul ; Kim, Joo-Hang...
info:eu-repo/semantics/altIdentifier/doi/10.1016/s1470-2045(18)30144-x.  , 2020
Link: https://hal.u-pec.fr/hal..
 
?
13

Transient IGF-1R inhibition combined with osimertinib eradi..:

Wang, Rong ; Yamada, Tadaaki ; Kita, Kenji...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490421/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Real‐world outcomes of chemoradiotherapy for unresectable S..:

Horinouchi, Hidehito ; Atagi, Shinji ; Oizumi, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520333/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Comparison of Carboplatin Plus Pemetrexed Followed by Maint..:

Okamoto, Isamu ; Nokihara, Hiroshi ; Nomura, Shogo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068674/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
1-15